Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
18°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Tickers
BMY
JNJ
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
October 11, 2024
Tickers
BMY
CATX
NEWS
Tags
Market News
BMY
CATX
From
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
Tickers
BMY
NEWS
RVPH
Tags
Schizophrenia
Expert Ideas
Briefs
From
Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
October 07, 2024
Tickers
BMY
Tags
Analyst Ratings
BZI/AAR
BMY
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Tickers
BMY
ELV
HIMS
HUM
Tags
BZI/AUOA
Options
LLY
From
Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
October 07, 2024
Tickers
AAPL
AI
BMY
GILD
Tags
MSFT
SPY
GOOG
From
Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
October 07, 2024
Tickers
BMY
CRM
PFE
Tags
BMY
Ian Read
CRM
From
Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
Tickers
BMY
NEWS
Tags
BMY
Market News
News
From
Benzinga
2 Passive-Income Stocks to Load Up On in October
October 03, 2024
Tickers
BMY
LMT
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
October 01, 2024
Tickers
BMY
Tags
BMY
Market News
Markets
From
Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
October 01, 2024
Tickers
BMY
IGMS
NEWS
Tags
IGMS
Market News
why it's moving
From
Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Tickers
BMY
PRME
Tags
Recent Press Releases
Market News
BMY
From
Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Tickers
BMY
NEWS
PRME
Tags
Briefs
Biotech
Movers
From
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Tickers
BMY
MRNA
PFE
Tags
BMY
PFE
MRNA
From
Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
Movers
Biotech
Benzinga
From
Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
Tickers
BABA
BHP
BMY
BP
Tags
BMY
Markets
Market News
From
Benzinga
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
September 27, 2024
Tickers
BMY
NEWS
PRTC
Tags
why it's moving
BMY
Market News
From
Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
September 27, 2024
Tickers
ATCH
BMY
CDIO
DUO
Tags
ATCH
Losers
Movers
From
Benzinga
Wall Street On Wait-And-Watch Mode Ahead Of Inflation Data, Bitcoin Holds Above 65.5K: Analyst Says Volatility Ahead Providing Better Entry Point Into Long-term Bull Market
September 27, 2024
Tickers
BB
BITCOMP
BMY
COST
Tags
News
Michelle Bowman
COST
From
Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Tickers
BGNE
BMY
MRK
NEWS
Tags
Stories That Matter
Benzinga
Biotech
From
Benzinga
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
September 25, 2024
Tickers
BMY
NEWS
NVO
TSVT
Tags
Analyst Color
Market News
why it's moving
From
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
BZI/AUOA
JNJ
BHVN
From
Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Health Care
ABBV
Top Stories
From
Benzinga
Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy
September 18, 2024
Tickers
BMY
NEWS
Tags
News
Large Cap
Briefs
From
Benzinga
What Analysts Are Saying About Bristol-Myers Squibb Stock
September 16, 2024
Tickers
BMY
Tags
Market News
Benzinga
BMY
From
Benzinga
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
September 16, 2024
Tickers
BEP
BMY
RPRX
Tags
BEP
RPRX
Recent Press Releases
From
Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
September 14, 2024
Tickers
BMY
GILD
Tags
BMY
GILD
Market News
From
Motley Fool
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
September 09, 2024
Tickers
BIIB
BMY
NEWS
Tags
Politics
Market News
Edge Project
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
AZN
why it's moving
BMY
From
Benzinga
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
September 08, 2024
Tickers
BMY
RPRX
Tags
Market News
Recent Press Releases
RPRX
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.